INCIDENCE AND RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DIRECT-ACTING ANTIVIRALS (DAAS).

被引：0
|
作者：
Leal, Cassia [1 ,2 ]
Teixeira, Rosangela [3 ]
Perez, Renata M. [4 ]
Theodoro, Carmem Ferguson [2 ]
Guarana, Thais [2 ]
Strogoff De Mattos, Jorge Paulo [5 ]
Noronha, Tatiana Guimaraes [6 ]
Aparecida Pinto, Paulo De Tarso [1 ]
Oliveira, Solange Artimos [5 ]
机构：
[1] Hosp Fed Servidores Estado Rio De Janeiro, Gastroenterol & Hepatol, Rio De Janeiro, Brazil
[2] Univ Fed Fluminense, Gastroenterol & Hepatol Unit, Rio De Janeiro, Brazil
[3] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[4] Univ Hosp Clementino Fraga Filho Ufrj, Hepatol, Rio De Janeiro, Brazil
[5] Fluminense Fed Univ, Clin Med Dept, Rio De Janeiro, Brazil
[6] Fluminense Fed Univ, Dept Materno Infantil, Rio De Janeiro, Brazil
来源：
HEPATOLOGY | 2023年 / 77卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5037
引用
收藏
页码：E149 / E150
页数：2
相关论文
共 50 条
  • [41] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Kazuto Tajiri
    Hiroyuki Ito
    Kengo Kawai
    Yoshiro Kashii
    Yuka Hayashi
    Aiko Murayama
    Masami Minemura
    Terumi Takahara
    Yukihiro Shimizu
    Ichiro Yasuda
    World Journal of Hepatology, 2022, 14 (06) : 1190 - 1199
  • [42] Risk of hepatocellular carcinoma for patients treated with direct-acting antivirals: steps after hepatitis C virus eradication to achieve elimination
    Lee, Mei-Hsuan
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
  • [43] A genetic risk score predicts de novo hepatocellular carcinoma in hepatitis C cirrotic patients treated with direct-acting antivirals
    Degasperi, Elisabetta
    Galmozzi, Enrico
    Pelusi, Serena
    D'ambrosio, Roberta
    Soffredini, Roberta
    Borghi, Marta
    Perbellini, Riccardo
    Facchetti, Floriana
    Iavarone, Massimo
    Sangiovanni, Angelo
    Bruccoleri, Mariangela
    Valenti, Luca
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2020, 73 : S208 - S209
  • [44] Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
    Cabibbo, G.
    Cacciola, I.
    Cannavo, M. R.
    Madonia, S.
    Calvaruso, V.
    Petta, S.
    Distefano, M.
    Larocca, L.
    Prestileo, T.
    Tine, F.
    Digiacomo, A.
    Bertino, G.
    Giannitrapani, L.
    Benanti, F.
    Davi, A.
    Volpes, R.
    Scalisi, I.
    Iacobello, C.
    Mazzola, G.
    Cartabellotta, F.
    Guarneri, L.
    Portelli, V.
    Averna, A.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E59 - E59
  • [45] Type 2 Diabetes Mellitus and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals
    Laura, Iliescu Elena
    Letitia, Toma
    Camelia, Diaconu
    Anca, Zgura
    Nicolae, Bacalbasa
    Adriana, Mercan-Stanciu
    PROCEEDINGS OF 6TH INTERNATIONAL CONFERENCE ON INTERDISCIPLINARY MANAGEMENT OF DIABETES MELLITUS AND ITS COMPLICATIONS (INTERDIAB), 2020, : 150 - 155
  • [46] Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals
    Calvaruso, V.
    Cabibbo, G.
    Cacciola, I.
    Petta, S.
    Madonia, S.
    Bellia, A.
    Stefano, M. D.
    Giannitrapani, L.
    Tine, F.
    Magro, A.
    Davi, A.
    Larocca, L.
    Ardiri, A.
    Digiacomo, A.
    Gussio, M.
    Guarneri, L.
    Scalisi, I.
    Mazzola, G.
    Cartabellotta, F.
    Savalli, F.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Camma, C.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S23 - S24
  • [47] Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
    Guarino, Maria
    Sessa, Anna
    Cossiga, Valentina
    Morando, Federica
    Caporaso, Nicola
    Morisco, Filomena
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (24) : 2582 - 2595
  • [48] Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
    Maria Guarino
    Anna Sessa
    Valentina Cossiga
    Federica Morando
    Nicola Caporaso
    Filomena Morisco
    World Journal of Gastroenterology, 2018, (24) : 2582 - 2595
  • [49] Early Viral Kinetics in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
    Garashova, Dilruba
    Balkan, Ilker Inanc
    Oezaras, Resat
    Kuskucu, Mert Ahmet
    Oezdil, Aysenur
    Mustafayev, Khalis
    Kaya, Sibel Yildiz
    Karaali, Ridvan
    Mete, Bilguel
    Ayguen, Goekhan
    Saltoglu, Nese
    Tabak, oemer Fehmi
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2023, 29 (03): : 101 - 107
  • [50] Effect of direct-acting antivirals on hepatocellular carcinoma incidence in hepatitis C virus-related cirrhosis
    Navani, V.
    Chan, P.
    Borchard, J.
    Ladera, A.
    Coppock, J.
    Turner, I.
    Shackel, N.
    Levy, M.
    Davison, S.
    Prakoso, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 75 - 75
12345